Novavax, Inc. (NVAX)
NASDAQ: NVAX · IEX Real-Time Price · USD
4.930
+0.220 (4.67%)
At close: May 3, 2024, 4:00 PM
4.910
-0.020 (-0.41%)
After-hours: May 3, 2024, 7:57 PM EDT
Novavax Employees
Novavax had 1,543 employees on February 23, 2024. The number of employees decreased by 449 or -22.54% compared to the previous year.
Employees
1,543
Change (1Y)
-449
Growth (1Y)
-22.54%
Revenue / Employee
$637,528
Profits / Employee
-$353,248
Market Cap
692.19M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Feb 23, 2024 | 1,543 | -449 | -22.54% |
Feb 21, 2023 | 1,992 | 451 | 29.27% |
Feb 21, 2022 | 1,541 | 750 | 94.82% |
Feb 24, 2021 | 791 | 626 | 379.39% |
Mar 6, 2020 | 165 | -214 | -56.46% |
Mar 12, 2019 | 379 | 32 | 9.22% |
Mar 9, 2018 | 347 | -8 | -2.25% |
Feb 23, 2017 | 355 | -88 | -19.86% |
Feb 24, 2016 | 443 | 135 | 43.83% |
Feb 23, 2015 | 308 | 95 | 44.60% |
Mar 6, 2014 | 213 | 76 | 55.47% |
Mar 4, 2013 | 137 | 25 | 22.32% |
Mar 8, 2012 | 112 | 24 | 27.27% |
Mar 22, 2011 | 88 | -6 | -6.38% |
Mar 12, 2010 | 94 | 24 | 34.29% |
Mar 10, 2009 | 70 | -16 | -18.60% |
Mar 10, 2008 | 86 | 26 | 43.33% |
Feb 28, 2007 | 60 | 8 | 15.38% |
Mar 6, 2006 | 52 | -108 | -67.50% |
Mar 15, 2005 | 160 | 43 | 36.75% |
Mar 15, 2004 | 117 | -4 | -3.31% |
Mar 28, 2003 | 121 | -52 | -30.06% |
Mar 15, 2002 | 173 | 46 | 36.22% |
Dec 31, 2000 | 127 | 92 | 262.86% |
Dec 31, 1999 | 35 | 19 | 118.75% |
Dec 31, 1998 | 16 | 1 | 6.67% |
Dec 31, 1997 | 15 | -3 | -16.67% |
Dec 31, 1996 | 18 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
NVAX News
- 1 day ago - Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement - Accesswire
- 18 days ago - Hedge fund Shah Capital recommends two new candidates for Novavax board - Reuters
- 18 days ago - Novavax failed to capitalize on fears surrounding mRNA vaccines, activist investor says - Market Watch
- 4 weeks ago - Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024 - PRNewsWire
- 2 months ago - Novavax to Participate in TD Cowen's 44th Annual Health Care Conference - PRNewsWire
- 2 months ago - Novavax Stock Sinks as Revenue Misses Estimates in ‘Transition Year' - Barrons
- 2 months ago - Novavax sees 2024 sales flat to lower, aims to pick up COVID vaccine market share - Reuters
- 2 months ago - Novavax misses quarterly estimates, but vaccine maker narrows losses as it slashes costs - CNBC